Biodesix inc.

Medical-Specialities

BDSX


Executive/
Director

Price

  • Last Close
  • $ 1.32
    $ -0.03 -2.58 %
    Dec 10, 2024
  • 52-Week High/Low
  • $2.13 - $1.17
  • YTD
  • -28.3%

  • Trading Volume
  • 15,138
  • Market Cap Full
  • $ 119.4M
  • Shares Outstanding
  • 90.5M
    Nov 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 0.7% -68.1% -19.1% -22.3%
Q2 - - - - - 4% -35% -3% -33.9% 1.4%
Q3 - - - - - 8% -37.8% -22.6% 34.2% -
Q4 - - - - - 57.4% -35.6% 81.1% 7.6% -
J F M A M J J A S O N D
2024 8.7% -23% -7.1% 4.2% - - - - - - - -
2023 4.4% -14.2% -9.7% -7% -19.1% -12.1% -3.3% 31.9% 5.1% -13.9% 4.9% 23.5%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%-74%-57%-20%-28%

Earnings

2021 2022 2023
Q1 -0.26 -0.5 -0.24
Q2 -0.41 -0.4 -0.17
Q3 -0.41 -0.34 -0.14
Q4 -0.5 -0.31 -
A -1.6 -1.6 -0.55

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 26.6 31.3 78
Jun - 26.9 39.8 78.5
Sep - 27 40 78.6
Dec 26.5 27 42.1 90.5

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 3.2 9.2 7.7 12.5 -
Total Asset Turnover 0.4 0.7 0.4 0.6 -
Leverage
Debt Ratio 0.5 0.2 0.2 1.9 -
Debt – Equity Ratio 1.2 0.5 0.4 -0.1 -
Interest Coverage -3.6 -20.5 -2.9 -6.8 -
Equity multiplier 0.6 0.3 0.2 - -